文献速递传染病防控与疫情报告免疫规划

追踪葡萄牙甲型肝炎流行病学转变:2001至2002年与2015至2016年两次全国血清学调查的血清流行率比较

Tracking epidemiological shifts in hepatitis A in Portugal: a comparison of seroprevalence between two nationwide surveys, 2001 to 2002 and 2015 to 2016.
PubMed 文献 · Euro Surveill · 2025-01-01

该研究分析葡萄牙2001-02年和2015-16年两次≥2岁人群横断面血清学调查,抗-HAV IgG总体血清流行率从67.3%(95%CI:64.2-70.3,n=1,642)降至56.3%(95%CI:52.4-60.2,n=2,052),下降11个百分点;出生队列分析显示血清流行率与出生队列(队列效应)更相关,而非特定时间点。作者认为高易感性和甲肝血清阳性者年龄分布变化提示葡萄牙需修订未来疫苗接种策略。

要点

  • 抗-HAV IgG血清流行率2001-02年67.3%(95%CI:64.2-70.3,n=1,642)vs 2015-16年56.3%(95%CI:52.4-60.2,n=2,052),下降11个百分点。
  • 1981-90年出生队列血清流行率两次调查分别为16.7%和18.7%,提示队列效应而非时间点效应。
  • ≥30岁者、1980年代前出生者及教育程度较低者血清流行率较高。

核心结论

  • 葡萄牙人群抗-HAV抗体免疫特征在过去数十年发生转变。
  • 甲肝高易感性和血清阳性者年龄分布变化提示葡萄牙需修订未来疫苗接种策略。

研究设计与样本

  • 分析2001-02年和2015-16年两次≥2岁人群横断面血清流行率研究数据,按年龄、性别和地区加权后,按出生队列(1911-2014年)分析并用泊松回归比较。

主要发现

  • 抗-HAV IgG总体血清流行率2001-02年为67.3%(95%CI:64.2-70.3,n=1,642),2015-16年为56.3%(95%CI:52.4-60.2,n=2,052),下降11个百分点。
  • 1981-90年出生队列血清流行率两次调查分别为16.7%和18.7%。
  • ≥30岁者、1980年代前出生者及教育程度较低者血清流行率较高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis A incidence in Portugal declined from 20.1 to 0.4/100,000 population between 1987 and 2023, changing non-vaccinated population susceptibility. This shift has contributed to more frequent outbreaks, including in 2024-25, highlighting the need to enhance surveillance and integrate serological data. AIM: We aimed to describe the exposure profile of the Portuguese population to hepatitis A virus (HAV) over time by estimating and comparing the seroprevalence of hepatitis A in two nationwide surveys. METHODS: Data from two cross-sectional seroprevalence studies performed in 2001-02 and 2015-16 in the population aged ≥ 2 years were analysed. Seroprevalence was weighted for population distribution by age, sex and region, and then analysed by birth cohort (1911 -2014) and compared using Poisson regression. RESULTS: Overall prevalence of anti-HAV IgG antibodies was 67.3% (95% CI: 64.2-70.3) in 2001-02 (n = 1,642) and 56.3% (95% CI: 52.4-60.2) in 2015-16 (n = 2,052), showing an 11-percentage-point decline. Birth cohort analysis revealed consistent seroprevalence within each cohort in both surveys, i.e. seroprevalence for the 1981-90 birth cohort was 16.7% and 18.7%, respectively, suggesting that higher seroprevalence is more closely associated with birth cohort (cohort effect) rather than a specific time point. Additionally, we found that individuals aged ≥ 30 years, born before the 1980s, and those with lower education had higher seroprevalence. CONCLUSIONS: The immunological profile of anti-HAV antibodies in the Portuguese population has shifted over the last decades. High susceptibility and shifting age distribution of Hepatitis A-seropositive individuals highlight the need to revise future vaccination strategies in Portugal.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Manageiro V, Matos R, Palminha P, et al. Tracking epidemiological shifts in hepatitis A in Portugal: a comparison of seroprevalence between two nationwide surveys, 2001 to 2002 and 2015 to 2016. Euro Surveill. 2025. PMID: 40970306. doi:10.2807/1560-7917.ES.2025.30.37.2500020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。